BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 24838846)

  • 1. Metabolomics approaches and applications in prostate cancer research.
    Zhang A; Yan G; Han Y; Wang X
    Appl Biochem Biotechnol; 2014 Sep; 174(1):6-12. PubMed ID: 24838846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolomics in diagnosis and biomarker discovery of colorectal cancer.
    Zhang A; Sun H; Yan G; Wang P; Han Y; Wang X
    Cancer Lett; 2014 Apr; 345(1):17-20. PubMed ID: 24333717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolomics in noninvasive breast cancer.
    Zhang AH; Sun H; Qiu S; Wang XJ
    Clin Chim Acta; 2013 Sep; 424():3-7. PubMed ID: 23669185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Putative molecular signatures for the imaging of prostate cancer.
    Yang S Y; Adelstein J; Kassis AI
    Expert Rev Mol Diagn; 2010 Jan; 10(1):65-74. PubMed ID: 20014923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-resolution NMR spectroscopy of human body fluids and tissues in relation to prostate cancer.
    Kumar V; Dwivedi DK; Jagannathan NR
    NMR Biomed; 2014 Jan; 27(1):80-9. PubMed ID: 23828638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New opportunities from the cancer metabolome.
    Aboud OA; Weiss RH
    Clin Chem; 2013 Jan; 59(1):138-46. PubMed ID: 23150057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beyond PSA: are new prostate cancer biomarkers of potential value to New Zealand doctors?
    Ng L; Karunasinghe N; Benjamin CS; Ferguson LR
    N Z Med J; 2012 Apr; 125(1353):59-86. PubMed ID: 22522272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent advances in metabolomics in oncology.
    O'Connell TM
    Bioanalysis; 2012 Feb; 4(4):431-51. PubMed ID: 22394143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolomic profiling for the identification of novel diagnostic markers in prostate cancer.
    Lucarelli G; Rutigliano M; Galleggiante V; Giglio A; Palazzo S; Ferro M; Simone C; Bettocchi C; Battaglia M; Ditonno P
    Expert Rev Mol Diagn; 2015; 15(9):1211-24. PubMed ID: 26174441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The method for early diagnosis of the gastric cancer based metabolomics research].
    Furina RR; Ryzhkov VL; Mitrakova NN; Koptina AV; Safiullin IK; Lychagin KA; Eroshkin PR
    Eksp Klin Gastroenterol; 2014; (10):14-7. PubMed ID: 25911924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Power of metabolomics in diagnosis and biomarker discovery of hepatocellular carcinoma.
    Wang X; Zhang A; Sun H
    Hepatology; 2013 May; 57(5):2072-7. PubMed ID: 23150189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolomic signatures of aggressive prostate cancer.
    McDunn JE; Li Z; Adam KP; Neri BP; Wolfert RL; Milburn MV; Lotan Y; Wheeler TM
    Prostate; 2013 Oct; 73(14):1547-60. PubMed ID: 23824564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New biomarkers in prostate cancer.
    Crawford ED; Ventii K; Shore ND
    Oncology (Williston Park); 2014 Feb; 28(2):135-42. PubMed ID: 24701701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biomarkers for prostate cancer detection.
    Reed AB; Parekh DJ
    Expert Rev Anticancer Ther; 2010 Jan; 10(1):103-14. PubMed ID: 20014890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Application of metabolomics to prostate cancer.
    Trock BJ
    Urol Oncol; 2011; 29(5):572-81. PubMed ID: 21930089
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolomics in cancer biomarker discovery: current trends and future perspectives.
    Armitage EG; Barbas C
    J Pharm Biomed Anal; 2014 Jan; 87():1-11. PubMed ID: 24091079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Other biomarkers for detecting prostate cancer.
    Nogueira L; Corradi R; Eastham JA
    BJU Int; 2010 Jan; 105(2):166-9. PubMed ID: 19930175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emerging field of metabolomics: big promise for cancer biomarker identification and drug discovery.
    Patel S; Ahmed S
    J Pharm Biomed Anal; 2015 Mar; 107():63-74. PubMed ID: 25569286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic signatures of malignant progression in prostate epithelial cells.
    Teahan O; Bevan CL; Waxman J; Keun HC
    Int J Biochem Cell Biol; 2011 Jul; 43(7):1002-9. PubMed ID: 20633696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabonomics of human colorectal cancer: new approaches for early diagnosis and biomarker discovery.
    Ni Y; Xie G; Jia W
    J Proteome Res; 2014 Sep; 13(9):3857-70. PubMed ID: 25105552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.